The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Three-Year Follow-up after Unilateral Subretinal Delivery of Adeno-Associated Virus in Patients with Leber Congenital Amaurosis Type 2
Open accessAbstract
Objective The aim of the current study is to show the clinical data of long-term (3 year) follow-up of five patients affected by Leber Congenital Amaurosis type 2 (LCA2) treated with a single unilateral injection of AAV2-hRPE65v2. Design clinical trial Participants five LCA2 patients with RPE65 gene mutations Methods After informed consent and confirmation of trial eligibility criteria, the eye with worse visual function was selected for subretinal delivery of Adeno-Associated Virus (AAV2-hRPE65v2). Subjects were evaluated before and after surgery at designated follow-up visits (1, 2, 3, 14, 30, 60, 90, 180, 270, 365 days, 1.5 years and 3 years) by complete ophthalmic examination. Efficacy for each subject was monitored with best corrected visual acuity, kinetic visual field, nystagmus testing and pupillary light reflex. Main Outcome Measures best corrected visual acuity, kinetic visual field, nystagmus testing and pupillary light reflex. Results The data showed a statistically significant improvement of best corrected visual acuity between baseline and 3 years after treatment in the treated eye (p<0.001). In all patients we observed an enlargement of the areas of visual field, which remained stable till 3 years post injection (average values: baseline 1058 deg2 vs 3 years post treatment: 4630 deg2) and a reduction of the nystagmus frequency compared to baseline at the 3 year time-point. Furthermore, a statistically significant difference was observed in the pupillary constriction of the treated eye (p<0.05) compared to the untreated eye in three patients at 1 and 3-year time-points. No patients suffered serious adverse events related to the vector in the 3 year post-injection period. Conclusions The long-term follow-up data (3 years) on the 5-patient Italian cohort involved in the LCA2 gene therapy clinical trial clearly showed a stability of improvement in visual and retinal function that had been achieved a few months after treatment. Longitudinal data analysis showed that the maximum improvement was achieved within six months after treatment, and the visual improvement was stable up to the last observed time-point.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Self-citationEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Hauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865
Self-citationLeber congenital amaurosis: Genes, proteins and disease mechanisms
den Hollander, A. I., Roepman, R., Koenekoop, R. K., & Cremers, F. P. M. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.003 · Cited by 811
Jacobson, S. G. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.298 · Cited by 639
ISCEV standard for clinical pattern electroretinography (PERG): 2012 update
Bach, M., Brigell, M. G., Hawlina, M., Holder, G. E., Johnson, M. A., McCulloch, D. L., Meigen, T., & Viswanathan, S. (2013) · Documenta Ophthalmologica · doi:10.1007/s10633-012-9353-y · Cited by 634
Sieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 589
Simonelli, F., Maguire, A. M., Testa, F., Pierce, E. A., Mingozzi, F., Bennicelli, J. L., Rossi, S., Marshall, K., Banfi, S., Surace, E. M., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.277 · Cited by 553
Self-citationAAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
Bennett, J., Ashtari, M., Wellman, J., Marshall, K. A., Cyckowski, L. L., Chung, D. C., McCague, S., Pierce, E. A., Chen, Y., Bennicelli, J. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002865 · Cited by 395
Self-citationArtes, P. H., Iwase, A., Ohno, Y., et al. (2002) · PubMed · Cited by 360
Cideciyan, A. V., Hauswirth, W. W., Aleman, T. S., Kaushal, S., Schwartz, S. B., Boye, S. L., Windsor, E. A. M., Conlon, T. J., Sumaroka, A., Pang, J.-J., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.086 · Cited by 312
GEEQBOX: A MATLAB Toolbox for Generalized Estimating Equations and Quasi-Least Squares
Ratcliffe, S. J., & Shults, J. (2008) · Journal of Statistical Software · doi:10.18637/jss.v025.i14 · Cited by 295
Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy
Cideciyan, A. V. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.002 · Cited by 256
Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration
Midena, E., Vujosevic, S., Convento, E., Manfre', A., Cavarzeran, F., & Pilotto, E. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.119685 · Cited by 255
The Association between Visual Acuity and Central Retinal Thickness in Retinitis Pigmentosa
Sandberg, M. A., Brockhurst, R. J., Gaudio, A. R., & Berson, E. L. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1383 · Cited by 211
Visual acuity as an outcome measure in clinical trials of retinal diseases
Beck, R. W., Maguire, M. G., Bressler, N. M., Glassman, A. R., Lindblad, A. S., & Ferris, F. L. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.06.047 · Cited by 188
Lorenz, B., Wabbels, B., Wegscheider, E., Hamel, C. P., Drexler, W., & Preising, M. N. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.01.033 · Cited by 172
Simonelli, F., Ziviello, C., Testa, F., Rossi, S., Fazzi, E. M., Bianchi, P. E., Fossarello, M., Signorini, S. G., Bertone, C., Galantuomo, M. S., et al. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0068 · Cited by 153
Self-citationISCEV standard for clinical pattern electroretinography—2007 update
Holder, G. E., Brigell, M., Hawlina, M., Meigen, T., Vaegan, & Bach, M. (2007) · Documenta Ophthalmologica · doi:10.1007/s10633-007-9053-1 · Cited by 145
Walia, S., Fishman, G. A., Jacobson, S. G., Alemán, T. S., Koenekoop, R. K., Traboulsi, E. I., Weleber, R. G., Pennesi, M. E., Héon, E., Drack, A. V., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.09.056 · Cited by 121
An alternative approach to the analysis of longitudinal data via generalized estimating equations
Chaganty, N. R. (1997) · Journal of Statistical Planning and Inference · doi:10.1016/s0378-3758(96)00203-0 · Cited by 105
Variability of Visual Field Measurements in Normal Subjects and Patients With Retinitis Pigmentosa
Ross, D., Fishman, G. A., Gilbert, L. D., et al. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030806021 · Cited by 96
Fundus autofluorescence in children and teenagers with hereditary retinal diseases
Wabbels, B., Demmler, A., Paunescu, K., Wegscheider, E., Preising, M. N., & Lorenz, B. (2005) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-0043-2 · Cited by 71
Chen, F. K., Patel, P. J., Webster, A. R., Coffey, P. J., Tufail, A., & da Cruz, L. (2010) · Retina · doi:10.1097/iae.0b013e3181e46af3 · Cited by 47
Macular Function Assessed by Microperimetry in Patients with Enhanced S-Cone Syndrome
Sohn, E. H., Chen, F. K., Rubin, G. S., Moore, A. T., Webster, A. R., & MacLaren, R. E. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.10.046 · Cited by 47
Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients
Melillo, P., Pecchia, L., Testa, F., Rossi, S., Bennett, J., & Simonelli, F. (2012) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-11-40 · Cited by 38
Self-citationVolpe, N. J., Dadvand, L., Kim, S. K., Maguire, M. G., Ying, G., Moster, M. L., & Galetta, S. L. (2009) · Current Eye Research · doi:10.1080/02713680902993891 · Cited by 14
Cited by
Russell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31868-8 · Cited by 1,952
Self-citationAdeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
Gene therapy returns to centre stage
Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184
Long-Term Effect of Gene Therapy on Leber’s Congenital Amaurosis
Bainbridge, J. W. B., Mehat, M. S., Sundaram, V., Robbie, S. J., Barker, S. E., Ripamonti, C., Georgiadis, A., Mowat, F. M., Beattie, S. G., Gardner, P. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414221 · Cited by 743
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Costa Verdera, H., Kuranda, K., & Mingozzi, F. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.12.010 · Cited by 641
Metadata
- Authors
- Testa, F., Maguire, A. M., Rossi, S., Pierce, E. A., Melillo, P., Marshall, K., Banfi, S., Surace, E. M., Sun, J., Acerra, C., Wright, J. F., Wellman, J., High, K. A., Auricchio, A., Bennett, J., & Simonelli, F.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 120
- Issue
- 6
- Pages
- 1283-1291
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2023962213
- Cited by
- 330
- References
- 28
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.